Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AZ304
Cat. No.:
OB0225LY-0314
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
AZ304 is a small molecule inhibitor that is primarily used to study cancer-related pathways.
Synonym:
942507-42-8; 3-(2-Cyanopropan-2-yl)-N-(3-((7-methoxyquinazolin-4-yl)amino)-4-methylphenyl)benzamide; 3-(2-Cyanopropan-2-yl)-N-[3-[(7-methoxyquinazolin-4-yl)amino]-4-methylphenyl]benzamide; 3-(1-Cyano-1-methylethyl)-N-{3-[(7-methoxyquinazolin-4-yl)amino]-4-methylphenyl}benzamide
CAS No.:
942507-42-8
Compound CID:
16202218
Formula:
C27H25N5O2
Formula Weight:
451.52
Specification
Relative Density:
1.270 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
AZ304 can be used to study apoptosis and proliferation signaling pathways and help explore the mechanisms of tumorigenesis.
Library Information
Targets:
RTKs; Serine/Threonine kinases
Receptors:
B-Raf (V600E); B-Raf (WT); CSF1R; p38 MAPK; Raf
Pathways:
Tyrosine kinase/adaptors; MAPK; Autophagy
Plate Number:
AOCL-5
Plate Location:
a7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 110.74 mM
Ethanol Max Solubility:
4 mg/mL
Solubility:
Insoluble in water.
ALogP:
5.524
HBA_Count:
4
HBD_Count:
2
Rotatable Bond:
6
